SEI Investments’s enGene Therapeutics ENGN Stock Holding History
Bought
Maintained
Sold
Other funds holding ENGN
BCM
SL
ACA
SEI Investments's ENGN Position: Q3 2026 in Review
SEI Investments sold out of enGene Therapeutics (ENGN) in Q3 2026, closing a stake of 18,504 shares — an estimated $32K sold.
SEI Investments first reported a position in ENGN in Q1 2026 and held it in 2 quarters. The position peaked at $409K in Q1 2026. 60 funds tracked by Wall St. Rank hold ENGN as of Q3 2026.
- SEI Investments reported no remaining enGene Therapeutics position as of Q3 2026 after selling out during the quarter.
- SEI Investments sold 18,504 enGene Therapeutics shares in Q3 2026, an estimated $32K.
- SEI Investments first reported a position in enGene Therapeutics in Q1 2026 and held it in 2 quarters.
- SEI Investments's enGene Therapeutics position peaked at $409K in Q1 2026.
- 60 funds tracked by Wall St. Rank held enGene Therapeutics as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.